Modules
Wrenfield Medical Group, Corp.
Customer 1435
- Account Classification
- Research Institution Operating Instruments
- Classification Confidence
- High
- Sites
- Vendor
- Assigned Reps
- Owen Whitfield
- Website
- —
- Active Opportunity Count
- 2
- Published Count
- 2
- Revenue Base
- 1389.88
- Known GPBase
- 395.13
- Analyzer Platforms
- Medica EasyLyte
- Product Groups
- Medica Easylyte
- Recommended Contact
- Ian Abrams
- Backup Contact
- Kara Nakamura | Assistant Professor | kara.nakamura@wrenfieldmedicalgroupcorp.com
- Last Meaningful Activity
- 2026-06-11
- Customer Memory
- Rep-entered contact note exists; review before calling. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified transaction fact: platform/product group signal is Medica EasyLyte. Verified item fact: storage requirement Room. Rep-entered contact note exists; review before calling. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach.
- Evidence References
- Candidate CAND-5600720df21275563c2e46714e0f1083e696fd63b127b71e1f0ea8a3bd360453 | Customer 1435 | Candidate CAND-75c487b54ba98ac1501e38d6c5213f24a64457d488d4c1d1b63de4a491e5c657 | Customer 1435 | Item 525
Opportunities (2)
| Source Sheet | Report Run ID | Candidate ID | Opportunity ID | Opportunity Series ID | Final Disposition | Assigned Rep | Territory Rep | Source Rep | Customer | Customer ID | Site | City | State | Region | Account Classification | Classification Confidence | Analyzer Platform | Product Group | SKU | Item Description | Quote Doc No | Order Doc No | Deterministic Signal | Revenue Low | Revenue Base | Revenue High | GP Low | GP Base | GP High | Priority Score | Confidence | Open Order | Open Quote | Suppression Status | Next Best Action | Evidence Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Account Risk | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5600720df21275563c2e46714e0f1083e696fd63b127b71e1f0ea8a3bd360453 | OPP-1ff1b603e8c440e3b484275fce240884d6df515b11ae83b0e950b64adb2b6cc9 | SER-8296f8652d6f6f8b1deb559d33baa1716f51cc95993f4a6cba73c8c747c90c14 | Published | **** | **** | **** | Wrenfield Medical Group, Corp. | 1435 | Vendor | Atlanta | GA | Southeast | Research Institution Operating Instruments | High | — | — | — | — | — | — | Reduced Order Frequency; 2 independent signals; trailing 90-day revenue $0.00 versus $1004.51; trailing 180-day revenue $1004.51 versus $793.84; 0 days beyond expected account order date. | 502.25 | 1004.51 | 1506.76 | 143.5 | 287 | 430.5 | 63.05 | Medium | False | False | — | CALL | Candidate CAND-5600720df21275563c2e46714e0f1083e696fd63b127b71e1f0ea8a3bd360453 | Customer 1435 |
| Cross-Sell | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-75c487b54ba98ac1501e38d6c5213f24a64457d488d4c1d1b63de4a491e5c657 | OPP-91b5e7429273b2e3a7d5f03987581d42e079868c17864c8c1c4a5cf5279e6281 | SER-0a04943b168744066733407786e8463604cf58e39454a327f1261176478107f5 | Published | **** | **** | **** | Wrenfield Medical Group, Corp. | 1435 | Vendor | Atlanta | GA | Southeast | Research Institution Operating Instruments | High | Medica EasyLyte | Medica Easylyte | 2121 | [2121] Medica EasyLyte Solutions Pack, NA/K/Cl, 800mL Medica EasyLyte Solutions Pack, NA/K/Cl, 800mL | — | — | Verified by Description for Medica EasyLyte; item purchased by 7 of 17 comparable active sites (41.2%); peer median annual revenue $385.37. | 192.68 | 385.37 | 578.05 | 54.06 | 108.13 | 162.19 | 59.02 | Medium | False | False | — | CONFIRM_ANALYZER | Candidate CAND-75c487b54ba98ac1501e38d6c5213f24a64457d488d4c1d1b63de4a491e5c657 | Customer 1435 | Item 525 |